Please login to the form below

Not currently logged in
Email:
Password:

antidote

This page shows the latest antidote news and features for those working in and with pharma, biotech and healthcare.

Bad news for Portola as CHMP considers Factor Xa drugs

Bad news for Portola as CHMP considers Factor Xa drugs

for betrixaban, its oral, once-daily Factor Xa inhibitor, as well as antidote drug andexanet alfa. ... In October 2015 the FDA granted accelerated approval to Boehringer's Praxbind (idarucizumab) reversal agent, and the availability of the antidote seems

Latest news

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Licence, collaboration. 237.5. Portola Pharmaceuticals/ HealthCare Royalty Partners. AndexXa (andexanet alfa) - Factor Xa inhibitor antidote (phase IIIb/IV).

  • Deal Watch February 2016 Deal Watch February 2016

    merger. 106. † Portola Pharmaceuticals/ BMS| Pfizer. andexanet alfa as an antidote for apixaban and other Factor Xa inhibitors (pre-reg).

  • Modern anticoagulants threaten status quo Modern anticoagulants threaten status quo

    Portola is also developing PRT 064445, which is an antidote designed to reverse the activity of factor Xa inhibitors and low molecular weight heparins. ... Idrabiotaparinux sodium has the same pentasaccharidic structure as idraparinux sodium but has an

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • How to be a patient

    We can therefore provide a service by offering impartial, code-compliant information as an antidote to the 'alt-med' lobby.

  • How to be a patient

    We can therefore provide a service by offering impartial, code-compliant information as an antidote to the 'alt-med' lobby.

  • Ogilvy Healthworld

    Ogilvy Healthworld. 'We have a habit of divine discontent with our performance.It is an antidote to smugness.'So said David Ogilvy.

  • Ogilvy Healthworld

    Ogilvy Healthworld. 'We have a habit of divine discontent with our performance.It is an antidote to smugness.'So said David Ogilvy.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics